Altered mitochondrial function and HIV-associatedcardiometabolic disease in populations from South Africa and Kenya (MITO-SAKen)
The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).
Funding Fogarty Program
HIV-associated Noncommunicable Diseases Research at LMIC Institutions
Project Information in NIH RePORTER
Altered mitochondrial function and HIV-associatedcardiometabolic disease in populations from South Africa and Kenya (MITO-SAKen)
Principal Institution
Stellenbosch University
Principal Investigator(s) (PI)
Strijdom, Hans
Project Contact Information
Email:
jgstr@sun.ac.za
Year(s) Awarded
2022-2024
Country
Kenya; South Africa
Project Description
More than 50% of the global population with HIV lives in sub-Saharan Africa, with a high cardiometabolic disease burden. This exploratory study will, for the first time in the context of sub-Saharan Africa, provide evidence of mitochondrial damage in people living with HIV and cardiometabolic disease. This will help identify at-risk popu- lations, and flag therapies with mitochondrial toxicity.
Related World Regions / Countries
Related Global Health Research Topics